1261MO Updated results from a phase I/II study of mobocertinib (TAK-788) in NSCLC with EGFR exon 20 insertions (exon20ins) - Concepedia

Concepedia

Publication | Closed Access

1261MO Updated results from a phase I/II study of mobocertinib (TAK-788) in NSCLC with EGFR exon 20 insertions (exon20ins)

19

Citations

0

References

2020

Year

Greg J. Riely, Joel W. Neal, D. Ross Camidge, Alexander I. Spira, Zofia Piotrowska, Leora Horn, Daniel B. Costa, Anne S. Tsao, Jay Patel, Shirish M. Gadgeel,

Annals of Oncology

Phase I/ii StudyMedicinePharmacologyRadiation OncologyMolecular Medicine

No additional data available for this publication yet. Check back later!